Invesco Global Listed Private Equity ETFPSP
PSP
0
Funds holding %
of 6,823 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
45% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 11
2% more funds holding
Funds holding: 81 [Q2] → 83 (+2) [Q3]
4% more capital invested
Capital invested by funds: $153M [Q2] → $160M (+$6.79M) [Q3]
0% more funds holding in top 10
Funds holding in top 10: 2 [Q2] → 2 (+0) [Q3]
4.25% less ownership
Funds ownership: 66.22% [Q2] → 61.97% (-4.25%) [Q3]
30% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 30
Research analyst outlook
We haven’t received any recent analyst ratings for PSP.
Financial journalist opinion
Positive
Forbes
1 month ago
Collect 12% Yields By Investing Like A Billionaire In 2025
If you've been investing for a while, you've probably thought about private equity more than once. Adding exposure to “PE” firms, which buy and sell privately held businesses, is a great way to diversify beyond the big names of the S&P 500.
Negative
Seeking Alpha
2 months ago
PSP: Not My Preferred Private Markets Play
The Invesco Global Listed Private Equity ETF offers exposure to the private markets industry via publicly traded vehicles. PSP has delivered relatively weak historical performance for investors relative to the broader market. The ETF is highly diversified and includes significant exposure to BDCs.
Neutral
Business Wire
3 months ago
FDA Clears Abionic's IVD CAPSULE PSP for the Early Detection of Sepsis
EPALINGES, Switzerland--(BUSINESS WIRE)--Abionic, an emerging medical diagnostics company focused on rapid early detection technologies, announced today that its IVD CAPSULE PSP test has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to accelerate the Time-to-Detection of Sepsis. Already certified under the EU IVDR as of July 2022, this FDA clearance marks a pivotal moment for Abionic's expansion into the U.S. market. Sepsis is a global health threat affecting 50M pa.
Neutral
ETF Trends
4 months ago
Can ETFs Capture Private Equity Markets?
The world's largest asset managers are scrambling to devise new ways to package private investment opportunities into a passive ETF wrapper. Private assets are the fastest-growing market in the financial world — but could also prove the most challenging field for ETF providers to penetrate.
Positive
Seeking Alpha
11 months ago
PSP: A Public Way To Play Private Equity
Investing in public stocks of private equity firms can generate significant returns and benefit from professional management and strategic insights. The Invesco Global Listed Private Equity ETF allows investors to access the private equity sector and holds a diverse range of private equity firms. PSP has a large allocation to the financial sector and carries risks inherent to private equity investments, but can provide diversification benefits and potential relative strength against the sector.
Neutral
Seeking Alpha
1 year ago
PSP ETF: The Private Equity Diversifier Since Leverage Is Not That Bad
This thesis aims to address the needs of investors looking to diversify beyond equities and bonds. In this case private equity in the form of the PSP ETF represents a suitable alternative investment. For this matter, it is important to elaborate on the risks associated with PE especially given that both Warren Buffett and Charlie Munger are against investing in alternatives.
Positive
ETF Trends
1 year ago
This Week in ETFs: Private Equity Fund Debuts
The industry closed out November maintaining its pace of growth, rolling out another dozen new ETFs during the week. The launches included products from Goldman Sachs, Innovator, SP Funds, Counterpoint, YieldMax, Aztlan, and ETF newcomer Macquarie.
Charts implemented using Lightweight Charts™